Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Sep 01, 2008 (Vol. 28, No. 15)

Angiogenesis and Cancer Control

URL:www.moffitt.org/moffittapps/ccj//v6n5/article2.htm
  • Organization
  • A little light
Cells in developing tumors, the story goes, require more oxygen than normal cells due to their higher metabolic rate. Indeed, it is thought that the growth of blood vessels toward tumor cells is an important step in their development. It is no surprise, therefore, that drugs suppressing angiogenesis are readily sought for the treatment of cancers. The H. Lee Moffitt Cancer Center and Research Institute hosts this rather spotty collection of information on the subject of angiogenesis and cancer control. To find the goods, you’ll need to look around. The Search Clinical Trials database is the main offering here with options for selecting on the basis of disease type, drug, therapy, and phase of the disease. Most of the other links at the site are more aimed at general info or about the institute itself.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »